Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
The Team
Advisors
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Biomarker Capture Platform
SubB2M Pan-Cancer Probe
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Business Development
Products
Our Products
hTERT ICC Test
EXO-NET® Pan-Exosome
Product Technology & Features
Workflow and Performance
Product Ordering
Resources
Pipeline
Development Pipeline
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
Conferences & Events
Media
INOVIQ in the News
Contact
Contact Us
Subscribe to Email Alerts
INOVIQ in the News
Heading &
Sub-heading can be edited through HQI
Media
>
INOVIQ in the News
INOVIQ in the News
INOVIQ in the News
Filter by Year:
2023
2022
2021
2020
2018
2017
21-Dec-2021
Bard1 Awarded Biomedical Translation Bridge Funding to Develop Breast Cancer Tests
4-Nov-2021
BARD1 Life Sciences (ASX:BD1) Presentation, FNN Online Investor Event, October 2021
15-Feb-2021
INOVIQ reveals its SubB2M technology can detect all stages of breast cancer from a blood sample, 100% specificity and 95% sensitivity.
14-Feb-2021
INOVIQ share price doubles following positive announcement on ovarian cancer detection technology.
1
